Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
330.7500 -2.35 (-0.71%)
NSE May 23, 2025 15:31 PM
Volume: 2.1M
 

logo
Biocon Ltd.
31 Jul 2017
330.75
-0.71%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 6% YoY to | 934 crore (I-direct estimate: | 955 crore) due to sluggish API sales, adverse currency movement, GST impact, fire incident at Syngene and lower licensing income EBITDA margins contracted 595 bps YoY to 20.6% (I-direct estimate: 21.2%) mainly due to commissioning of the Malaysian plant Net profit fell 51% YoY to | 81 crore (I-direct estimate: | 88 crore) due to below expected operational performance, higher depreciation...
Biocon Ltd. has an average target of 389.25 from 4 brokers.
More from Biocon Ltd.
Recommended